 TARRYTOWN, N.Y. , Sept. 9, 2022 PRNewswire -- Regeneron Pharmaceuticals, Inc. NASDAQ: REGN will host a conference call and simultaneous webcast to share updates on the companys oncology portfolio in conjunction with the European Society for Medical Oncology ESMO Annual Congress on Monday, September 12, 2022. 